Literature DB >> 1642410

Epidemiology and prognostic factors in malignant melanoma.

D S Rigel1.   

Abstract

The rising rate of MM reflects damage to the skin that has been done in the past. If a difference is to be seen prospectively, we must use protection (sunscreens) and have suspicious areas evaluated early in their course so that MM can be treated when curable. Until further research yields a cure for advanced MM, the above approach remains the first line of defense in the fight against this cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1642410     DOI: 10.1097/00000637-199201000-00003

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  6 in total

1.  Sun protection practices among children with a family history of melanoma: a pilot study.

Authors:  Beth A Glenn; Roshan Bastani; L Cindy Chang; Rachna Khanna; Katherine Chen
Journal:  J Cancer Educ       Date:  2012-12       Impact factor: 2.037

2.  Transduction of HOXD3-antisense into human melanoma cells results in decreased invasive and motile activities.

Authors:  Yoshiko Okubo; Jun-ichi Hamada; Yoko Takahashi; Mitsuhiro Tada; Arata Tsutsumida; Keiji Furuuchi; Tetsuya Aoyama; Tsuneki Sugihara; Tetsuya Moriuchi
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

3.  Skin cancer of the head and neck.

Authors:  Yun-Hsuan Ouyang
Journal:  Semin Plast Surg       Date:  2010-05       Impact factor: 2.314

4.  Age as a prognostic factor in the malignant melanoma population.

Authors:  P F Austin; C W Cruse; G Lyman; K Schroer; F Glass; D S Reintgen
Journal:  Ann Surg Oncol       Date:  1994-11       Impact factor: 5.344

5.  Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.

Authors:  J Nip; S A Rabbani; H R Shibata; P Brodt
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

6.  Melanoma recurrence surveillance. Patient or physician based?

Authors:  C R Shumate; M M Urist; W A Maddox
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.